SHN’s Polycystic Kidney Disease (PKD) Clinic offers patients in Scarborough and beyond greater access to diagnosis and additional treatment options in the management of PKD. This chronic disease causes progressive cysts on the kidneys, enlarging them slowly, and leading patients to need dialysis until they must have their kidneys removed and undergo a transplant surgery.
SHN has partnered with Otsuka Canada Pharmaceutical Inc., manufacturer of JINARC (tolvaptan), the first treatment indicated to slow the progression of kidney enlargement in PKD. Patients who meet the conditions for treatment with JINARC, and who only have partial private health insurance coverage or none at all, can apply to the ORIJIN Patient Support Program sponsored by Otsuka, which offers financial assistance and compassionate access programs.
Along with the treatment, a key component to success with the PKD Clinic is SHN’s interprofessional team of experts. Research shows that early screening and management, which involves many health care providers including nephrologists, nurses, dietitians, social workers, and pharmacists, have led to positive patient outcomes and improved self-management of the disease.
Multi-Care Kidney Clinic
First floor, East Wing
Wednesdays (bi-weekly), 9 a.m. to noon